Literature DB >> 24981932

PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer.

Kazuya Shinmura1, Nobuya Kurabe, Masanori Goto, Hidetaka Yamada, Hiroko Natsume, Hiroyuki Konno, Haruhiko Sugimura.   

Abstract

Polo-like kinase 4 (PLK4) is a centrosomal protein that is involved in the regulation of centrosome duplication. This study aimed to determine whether the genetic abnormality of PLK4 is involved in human gastric cancer. First, we examined the status of PLK4 mRNA expression in 7 gastric cancer cell lines and 48 primary gastric cancers using an RT-PCR analysis. The upregulation of PLK4 mRNA expression was detected in 57.1 % (4/7) of the gastric cancer cell lines, and a novel PLK4 variant with exon 4, but without exon 5, was identified. In the primary gastric cancers, the upregulation of PLK4 mRNA expression in the cancerous cells was detected in 50.0 % (24/48) of the cases, and this upregulation was statistically significant (P value = 0.0139). Next, we established AGS gastric cancer cells capable of inducibly expressing PLK4 using the piggyBac transposon vector system and showed that PLK4 overexpression induced centrosome amplification and chromosome instability using immunofluorescence and FISH analyses, respectively. Furthermore, PLK4 overexpression suppressed primary cilia formation. Our current findings suggested that PLK4 is upregulated in a subset of primary gastric cancers and that PLK4 overexpression induces centrosome amplification and chromosome instability and causes the suppression of primary cilia formation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24981932     DOI: 10.1007/s11033-014-3546-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  43 in total

Review 1.  gamma-Tubulin.

Authors:  B R Oakley
Journal:  Curr Top Dev Biol       Date:  2000       Impact factor: 4.897

Review 2.  Centrosome clustering and chromosomal (in)stability: a matter of life and death.

Authors:  Alwin Krämer; Bettina Maier; Jiri Bartek
Journal:  Mol Oncol       Date:  2011-05-19       Impact factor: 6.603

3.  The Polo kinase Plk4 functions in centriole duplication.

Authors:  Robert Habedanck; York-Dieter Stierhof; Christopher J Wilkinson; Erich A Nigg
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

4.  Plk4 trans-autophosphorylation regulates centriole number by controlling betaTrCP-mediated degradation.

Authors:  Gernot Guderian; Jens Westendorf; Andreas Uldschmid; Erich A Nigg
Journal:  J Cell Sci       Date:  2010-06-01       Impact factor: 5.285

5.  Cep97 and CP110 suppress a cilia assembly program.

Authors:  Alexander Spektor; William Y Tsang; David Khoo; Brian David Dynlacht
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

6.  The SCF/Slimb ubiquitin ligase limits centrosome amplification through degradation of SAK/PLK4.

Authors:  Inês Cunha-Ferreira; Ana Rodrigues-Martins; Inês Bento; Maria Riparbelli; Wei Zhang; Ernest Laue; Giuliano Callaini; David M Glover; Mónica Bettencourt-Dias
Journal:  Curr Biol       Date:  2008-12-11       Impact factor: 10.834

7.  Cullin 1 functions as a centrosomal suppressor of centriole multiplication by regulating polo-like kinase 4 protein levels.

Authors:  Nina Korzeniewski; Leon Zheng; Rolando Cuevas; Joshua Parry; Payel Chatterjee; Brittany Anderton; Anette Duensing; Karl Münger; Stefan Duensing
Journal:  Cancer Res       Date:  2009-08-15       Impact factor: 12.701

8.  Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis.

Authors:  Lili Liu; Chris Zhiyi Zhang; Muyan Cai; Jia Fu; George Gong Chen; Jingping Yun
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

9.  Functional genomic screen for modulators of ciliogenesis and cilium length.

Authors:  Joon Kim; Ji Eun Lee; Susanne Heynen-Genel; Eigo Suyama; Keiichiro Ono; Kiyoung Lee; Trey Ideker; Pedro Aza-Blanc; Joseph G Gleeson
Journal:  Nature       Date:  2010-04-15       Impact factor: 49.962

10.  Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells.

Authors:  Michelle A Schultz; Sharika S Hagan; Amrita Datta; Yiguo Zhang; Michael L Freeman; Suresh C Sikka; Asim B Abdel-Mageed; Debasis Mondal
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more
  21 in total

Review 1.  Mixed signals from the cell's antennae: primary cilia in cancer.

Authors:  Thibaut Eguether; Michael Hahne
Journal:  EMBO Rep       Date:  2018-10-22       Impact factor: 8.807

2.  Downregulation of PLK4 expression induces apoptosis and G0/G1-phase cell cycle arrest in keloid fibroblasts.

Authors:  Ru-Lin Huang; Chuanqi Liu; Rao Fu; Yuxin Yan; Jing Yang; Xinggang Wang; Qingfeng Li
Journal:  Cell Prolif       Date:  2022-06-07       Impact factor: 8.755

Review 3.  PLK4: a promising target for cancer therapy.

Authors:  Yi Zhao; Xin Wang
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-06       Impact factor: 4.553

Review 4.  Role of Polo-Like Kinase 4 (PLK4) in Epithelial Cancers and Recent Progress in its Small Molecule Targeting for Cancer Management.

Authors:  Debra R Garvey; Gagan Chhabra; Mary A Ndiaye; Nihal Ahmad
Journal:  Mol Cancer Ther       Date:  2021-01-05       Impact factor: 6.009

5.  Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy.

Authors:  Zhenhua Li; Kun Dai; Chijuan Wang; Yawen Song; Feng Gu; Fangfang Liu; Li Fu
Journal:  J Cancer       Date:  2016-06-06       Impact factor: 4.207

6.  Loss of KLF14 triggers centrosome amplification and tumorigenesis.

Authors:  Guangjian Fan; Lianhui Sun; Peipei Shan; Xianying Zhang; Jinliang Huan; Xiaohong Zhang; Dali Li; Tingting Wang; Tingting Wei; Xiaohong Zhang; Xiaoyang Gu; Liangfang Yao; Yang Xuan; Zhaoyuan Hou; Yongping Cui; Liu Cao; Xiaotao Li; Shengping Zhang; Chuangui Wang
Journal:  Nat Commun       Date:  2015-10-06       Impact factor: 14.919

7.  Clinical Significance of Polo-Like Kinase 4 as a Marker for Advanced Tumor Stage and Dismal Prognosis in Patients With Surgical Gastric Cancer.

Authors:  Ting Cao; Shijie Yi; Xuefeng Yang; Qing Wu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

8.  MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway.

Authors:  Jie Bao; Yan Yu; Jianan Chen; Yuting He; Xiaolong Chen; Zhigang Ren; Chen Xue; Liwen Liu; Qiuyue Hu; Juan Li; Guangying Cui; Ranran Sun
Journal:  Cell Death Dis       Date:  2018-10-12       Impact factor: 8.469

9.  Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma.

Authors:  Simone Treiger Sredni; Anders W Bailey; Amreena Suri; Rintaro Hashizume; Xingyao He; Nundia Louis; Tufan Gokirmak; David R Piper; Daniel M Watterson; Tadanori Tomita
Journal:  Oncotarget       Date:  2017-11-24

Review 10.  Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.

Authors:  Karuna Mittal; Jaspreet Kaur; Meghan Jaczko; Guanhao Wei; Michael S Toss; Emad A Rakha; Emiel Adrianus Maria Janssen; Håvard Søiland; Omer Kucuk; Michelle Dian Reid; Meenakshi V Gupta; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2020-10-26       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.